Skip to main content
Premium Trial:

Request an Annual Quote

Generic Drug Manufacturer Teva Takes Majority Stake in Genomic Analysis Shop Immuneering

NEW YORK (GenomeWeb) – Teva Pharmaceutical Industries will acquire a 51 percent stake in genomic analysis firm Immuneering in a deal announced on Monday. 

Based in Cambridge, Massachusetts, Immuneering provides advanced data analysis services such as the analysis of gene expression, SNP, and protein concentration data, as well as next-generation sequencing data, including RNA-seq, exome sequencing, and whole-genome sequencing. The companies said they have collaborated during the past several years on research into genetic biomarkers and therapy-specific gene expression signatures, and the characterization of non-biological complex drugs. 

As part of its investment, Jerusalem-based Teva, which said it is the world's largest producer of generic drugs, will have the right of first refusal in projects related to Teva's objective of developing, personalizing, and improving central nervous system disorder treatments. The firms did not provide the dollar amount of Teva's investment in Immuneering. 

Teva President of Global R&D and CSO Michael Hayden noted in a statement Immuneering's capabilities in linking and interpreting disparate datasets that are enormous in size. "This capability is invaluable in capturing difficult-to-find signals, confirming them in follow-up experiments, and informing decision -making that de-risks and optimizes development of therapeutic approaches," he said.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.